Transgenomic (TBIO) Reports Q2 Loss of $0.10/Share
Tweet
Share
E-mailGet Alerts TBIO Hot Sheet
Price: $0.32 --0%
EPS Growth %: +37.8%
Financial Fact:
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS: -1.93M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
EPS Growth %: +37.8%
Financial Fact:
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS: -1.93M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q2 EPS of ($0.10), versus ($0.26) reported last year.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
- Humana (HUM) Tops Q1 EPS by 111c; reaffirms adjusted EPS outlook
- Biogen (BIIB) Tops Q1 EPS by 24c; reaffirms guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
